LRP1 and COVID-19: LRP1 is cardioprotective due to the activation of the reperfusion injury salvage kinase pathway after ischemia-reperfusion [25]. Although the underlying mechanisms of action are still poorly described, sLRP1 level alterations can be temporary in the disease course of COVID-19.